MRI引导的质子治疗集成技术的分析及展望  

Analysis and Perspectives of MRI-Guided Proton Therapy Integrated Technology

作　　者：王孝娃 王岚 孙伟名 WANG Xiaowa;WANG Lan;SUN Weiming(Shanghai Proton and Heavy Ion Center,Shanghai,201321;Shanghai Key Laboratory of Radiation Oncology,Shanghai,201321;Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy,Shanghai,201321)

机构地区：[1]上海市质子重离子医院,上海市201321 [2]上海市放射肿瘤学重点实验室,上海市201321 [3]上海质子重离子放射治疗工程技术研究中心,上海市201321

出　　处：《中国医疗器械杂志》2024年第6期618-623,共6页Chinese Journal of Medical Instrumentation

摘　　要：该文探讨了MRI引导的质子治疗(magnetic resonance imaging-guided radiation therapy, MRiPT)技术。通过精确控制剂量分布,MRiPT有望提高放射治疗的效果。该文回顾了MRiPT的发展历程,分析了其临床应用的潜力及所面临的技术挑战,并提出了可能的解决策略。MRiPT技术在提高治疗的精确度和降低副作用方面显示出显著优势,尤其在治疗复杂肿瘤方面表现出卓越的应用潜力。最后对MRiPT技术的未来发展进行了展望,并强调了优化系统的电磁兼容性和减少系统间干扰的重要性。This article explores the MRI-guided proton therapy(MRiPT)integrated technology,which is magnetic resonance imaging-guided radiation therapy.By precisely controlling dose distribution,MRiPT has the potential to enhance the efficacy of radiotherapy.This article reviews the development of MRiPT,analyzes its potential for clinical application,and discusses technical challenges and potential solutions.MRiPT technology offers significant advantages in improving treatment precision and reducing side effects,especially showing exceptional potential in the treatment of complex tumors.This article concludes by looking forward to the future development of MRiPT technology,emphasizes the importance of optimizing electromagnetic compatibility and reducing inter-system interference.

关 键 词：质子治疗 磁共振成像 技术集成 磁共振引导的质子治疗 

分 类 号：R197.39[医药卫生—卫生事业管理] TH774[医药卫生—公共卫生与预防医学]